Brief: Synact Pharma Gets SEK 17.7 Mln After Second Warrant Conversion
15/08/2025 07:56
Aug 15 (Reuters) - SynAct Pharma AB SYNACT.ST: TO RECEIVE SEK 17.7 MILLION AFTER SECOND CONVERSION OF WARRANTS OUTSTANDING WARRANTS NOW 1,375,000 Source text: ID:nMFN3JnfH0 Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026